Baculovirus vector (killed) Mycoplasma hyopneumoniae bacterin.
For use in healthy swine as an aid in the prevention of viremia, aid in the reduction of virus shedding and aid in the reduction of lymphoid infection caused by porcine circovirus type 2 (PCV2), and as an aid in the reduction of lung lesions due to Mycoplasma hyopneumoniae. PCV2 efficacy for at least 20 weeks following completion of vaccination has been demonstrated.
Reliable, 1 dose, ready-to-use combo vaccine for PCV2 and Mycoplasma hyopneumoniae
5-month PCV2 duration of immunity
Approved for use in pigs as early as 3 days of age (2-dose option)
Revision date indicates the date the MSDS or SDS was last revised. MSDS / SDS are
dated when they are originally issued AND when any significant change has been made
to the chemical compound or research has revealed a health or physical hazard different
from what was originally stated.